Friday, 24 November 2017

Eppendorf India extends training facility in Chennai

19 October 2017 | News

The state of the art facility is equipped with the latest range of life science research products.

Eppendorf India, a wholly owned subsidiary of Eppendorf AG, recently announced the extension of the training centre at its facility in Ambattur, Chennai. Eppendorf is committed to skill development and this measure further enhances the possibility of offering tailor made training programs for biotechnology students, faculties and researchers.

The state of the art facility is equipped with the latest range of life science research products covering the 3 competence areas of liquid handling, sample handling and cell handling. The centre is also equipped with laboratories for cell cultivation and Bioprocess applications.

Thomas Bachmann, Chairman & CEO of the Eppendorf Group said, “One of the cornerstones of our business strategy is to strengthen our global market position through targeted investments in both our sales structure and expansion of our training and service portfolio.

Vancheeswaran Sankaranarayanan, Managing Director & CEO, Eppendorf India stated, “During the decade-long presence of Eppendorf in India, we have extended significant support to the life sciences and biotechnology industry in India. Our dominant market position in India demonstrates the superiority of our products and underscores the importance of our training and service workshops extended to the clients’ R&D scientists continuously. With continually increasing demand for our premium products and services in India, Eppendorf India will work to increase considerably our customer-focused initiatives with our expanded training centre”.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Are Indian drug firms still cautious of executing big mergers & acquistions?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls